Relevance of the tumor necrosis factor alpha (TNFα) -308 promoter polymorphism in TNFα gene regulation

Journal of Inflammation

Volumn 46, Issue 1, 1996, Pages 32-41

  Brinkman, Brigitta M N ^a   Zuijdgeest, David ^a   Kaijzel, Eric L ^a   Breedveld, Ferdinand C ^a   Verweij, Cornells L ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b HUBRECHT INSTITUTE   (Netherlands)

Author keywords

ASTQ analysis; B cell line; cytokines; T cell line; transfection

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; AUTOIMMUNITY; GENE CONTROL; GENE LOCATION; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; PROMOTER REGION;

ALLELES; CELL LINE; CHLORAMPHENICOL O-ACETYLTRANSFERASE; ENHANCER ELEMENTS (GENETICS); GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; PLASMIDS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; T-LYMPHOCYTES; TETRADECANOYLPHORBOL ACETATE; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029966034     PISSN: 10787852     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Jäättelä M: Biologie activities and mechanisms of action of tumor necrosis factor-o/cachectin. Lab Invest 64:724-735, 1991.
2. Kwiatowski D, Hill AVS, Sambou I, Twumasi P, Castracane J, Manogue KR, Cerami A, Brewster DR, Greenwood BM: TNF concentration in fatal cerebral, nonfatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 336:1201-1204, 1990.
3. Saxne T, Palladino MA, Heinegârd D, Talal N, Wollheim FA: Detection of tumor necrosis factor a but not tumor necrosis factor in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum 31:1041-1045, 1988.
4. Braegger CP, Nichols S, Murch SH, Stephens S, MacDonald TT: Tumour necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet 339:89-91, 1992.
5. Bendtzen K, Morling N, Fomsgaard A, Svenson M, Jakobsen B, Odum N, Svejgaard A: Association between HLA-DR2 and production of tumour necrosis factor a and interleukin 1 by mononuclear cells activated by lipopolysaccharide. Scand J Immunol 28:599-606, 1988.
6. Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA, McDevitt HO: Heritable major histocompatibility complex class ll-associated differences in production of tumor necrosis factor a: Relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 87:1233-1237, 1990.
7. Poicot F, Briant L, Jongeneel CV, Mölvig J, Worsaae H, Abbal M, Thomsen M, Nerup J, Cambon-Thomsen A: Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-ct and TNF- by human mononuclear cells: A possible link to insulin-dependent diabetes mellitus. Eur J Immunol 23:224-231, 1993.
8. Shaw G, Kamen R: A conserved AD sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46:659-6167, 1986.
9. Wilson AG, de Vries N, Poicot F, di Giovine FS, van der Putte LBA, Duff GW: An allelic polymorphism within the human tumor necrosis factor α promoter region is strongly associated with HLA AI, B8, and DR3 alleles. J Exp Med 177:557-560, 1993.
10. Brinkman BMN, Giphart MJ, Verhoef A, Kaijzel EL, Naipal AMIH, Daha MR, Breedveld FC, Verweij CL: TNFA gene variants in relation to MHC alleles ind Felly's syndrome. Hum Immunol 41:259-266, 1994.
11. D'Alfonso S, Momigliano Richardi P: A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics 39:150-154, 1994.
12. Hamann A, Mantzoros C, Vidal-Puig A, Flier JS: Genetic variability in the TNF-α promoter is not associated with type II diabetes mellitus. Biochem Biophys Res Commun 211:833-839, 1995.
13. Brinkman BMN, Kaijzel EL, Huizinga TWJ, Giphart MJ, Breedveld FC, Verweij CL Detection of a novel C-insertion polymorphism within the human tumor necrosis factor alpha (TNFA) gene. Hum Genet 96:493-495.
14. Campbell R, Gosden CM, Bonthron DT: Parental origin of transcription from the human GNAS1 gene. J Med Genet 31:607-614, 1994.
15. Goldborough AS, Kornberg TB: Allele-specific quantification of Drosophila engrailed and invected transcripts. Proc Natl Acad Sci USA 91:12696-12700, 1994.
16. McGuire W, Hill AVS, Allisop CEM, Greenwood BM, Kwiatkowski D: Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 371:508-511, 1994.
17. Keffer J, Probert L, Cazlaris H, Georgopoulos S, Kas-laris E, Kioussis D, Kollias G: Transgenic mice expressing human tumour necrosis factor: A predictive genetic model of arthritis. EMBO J 13:4025-4031, 1991.
18. Durand DB, Bush MR, Morgan JG, Weiss A, Crabtree GR: A 275 basepair fragment at the 5' end of the interleukin 2 gene enhances expression from a heterologous promoter in response to signals from the T cell antigen receptor. J Exp Med 165:395-407, 1987.
19. Engelberts l. Moller A, Schoen GJM, van der Linden CJ, Buurman WA: Evaluation of measurement of human TNF in plasma by ELISA. Lymphokine Cytokine Res 10:69-76, 1991.
20. Sung SSJ, Bjorndahl JM, Wang CY, Kao HT, Fu SM: Production of tumor necrosis factor/cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phorbol myristate acetate and anti-CD3 antibody. J Exp Med 167:937-953, 1988.
21. Poicot F, Wilson AG, Nerup J, Duff GW: No independent association between a tumor necrosis factor-a promoter region polymorphism and insulin-dependent diabetes mellitus. Eur J Immunol 23:3043-3049, 1993.
22. Verjans GMGM, Brinkman BMN, van Doornik CEM, Kijlstra A, Verweij CL: Polymorphism of tumour necrosis factor-alpha (TNF-a) at position -308 in relation to ankylosing spondylitis. Clin Exp Immunol 97:45-47, 1994.
23. Wilson AG, Gordon C, di Giovine F, de Vries N, van de Putte L, Emery P, Duff GW: A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha, Eur J Immunol 24:191-195, 1994.
24. Cox A, Gonzalez AM, Wilson AG, Ward JD, Artlett CM, Welsh K, Duff GW: Comparative analysis of the genetic association of HLA-DR3 and tumour necrosis factor alpha with human IDDM. Diabetologica 37:500, 1994.